CYP1B1 Activates Wnt/β-Catenin Signaling through Suppression of Herc5-Mediated ISGylation for Protein Degradation on β-Catenin in HeLa Cells

10.1097/00008571-199602000-00002

10.1101/gr.103341.109

10.5487/TR.2017.33.2.079

10.1158/0008-5472.CAN-09-1691

10.1210/jc.2008-2218

10.1007/s11010-013-1758-8

10.1158/1078-0432.CCR-06-2430

10.1016/S1359-6101(00)00011-3

10.1016/j.cell.2006.10.018

10.1165/rcmb.2008-0485TR

10.1042/BJ20121284

10.1038/onc.2011.320

10.1074/jbc.M502814200

10.1074/jbc.M512830200

10.1128/MCB.01466-09

10.1016/j.cell.2010.09.033

10.1016/j.molcel.2010.05.002

10.1016/j.ygeno.2004.10.006

10.1016/S0014-5793(00)02371-1

10.1073/pnas.0600397103

10.1242/jcs.01338

10.1073/pnas.96.11.6273

10.1136/gut.2009.194068

10.1158/1078-0432.CCR-04-2111

Shimada, T, Hayes, CL, Yamazaki, H, Amin, S, Hecht, SS, Guengerich, FP, and Sutter, TR (1996). Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56, 2979-2984.

Murray, GI, Taylor, MC, McFadyen, MC, McKay, JA, Greenlee, WF, Burke, MD, and Melvin, WT (1997). Tumorspecific expression of cytochrome P450 CYP1B1. Cancer Res. 57, 3026-3031.

10.1158/0008-5472.CAN-04-0166

10.1093/toxsci/69.2.354

10.1016/S0378-4274(03)00216-9

Heidel, SM, Czuprynski, CJ, and Jefcoate, CR (1998). Bone marrow stromal cells constitutively express high levels of cytochrome P4501B1 that metabolize 7,12-dimethylbenz[a]anthracene. Mol Pharmacol. 54, 1000-1006.

10.1002/med.10050

Chun, YJ, Lee, SK, and Kim, MY (2005). Modulation of human cytochrome P450 1B1 expression by 2,4,3′,5′-tetramethoxystilbene. Drug Metab Dispos. 33, 1771-1776.

10.1016/j.bbrc.2005.08.038